FDA approves first self-administered flu vaccine spray
The Food and Drug Administration announced Friday it had broadened the approval of the FluMist nasal spray to become the first "self-administered" influenza vaccine — though a delay in the change means the vaccine will not be available to ship to homes until next year's flu season at the earliest.
GlobalData on MSN22d
EC approves GSK’s RSV vaccine for adults aged 50-59 years"EC approves GSK’s RSV vaccine for adults aged 50-59 years" was originally created and published by Pharmaceutical Technology ...
If approved, the co-administration of Arexvy and Shingrix could provide a more convenient vaccination regimen for patients ...
GSK released data from a Phase 3 trial evaluating the co-administration of Arexvy and Shingrix vaccines in adults 50+. The ...
GSK (NYSE:GSK) announced Wednesday that its Arexvy vaccine for respiratory syncytial virus (RSV) and its Shingrix vaccine for ...
AREXVY is approved for the prevention of lower respiratory ... Indication for SHINGRIX SHINGRIX is an FDA-approved vaccine for the prevention of shingles (herpes zoster) in: Adults 50 years ...
Zevra Therapeutics Inc. (ZVRA) made headlines yesterday with a landmark FDA approval for its innovative drug, MIPLYFFA, in the ...
Sanofi said the Food and Drug Administration has approved Sarclisa as a first line combined treatment option for adult patients with newly diagnosed multiple myeloma who aren't eligible for autologous ...
The U.S. Food and Drug Administration has authorized the first-ever over-the-counter hearing aid software intended to be used ...
Moderna pushed back its break-even goal by two years on Thursday as it delayed the timeline for developing several key ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback